Frazier Healthcare and PCI acquire AndersonBrecon

Published: 14-May-2013 Featured companies: PCI Pharma Services
Packaging Finance

Combined business will create the largest global pharmaceutical contract packer


Frazier Healthcare and Packaging Coordinators have completed the acquisition of pharmaceutical packager AndersonBrecon from its parent company AmerisourceBergen Corporation. AndersonBrecon will now merge with and operate as Packaging Coordinators (PCI).

Frazier Healthcare is a leading provider of growth equity and venture capital to high growth and emerging healthcare companies. PCI offers unparalleled expertise in a range of proprietary pharmaceutical and biotechnology packaging innovations and provides cutting-edge customised healthcare packaging solutions that improve patient adherence and uphold the most stringent safety requirements.

‘We are extremely excited to bring the experience of the AndersonBrecon team to propel our national presence and establish a European footprint for PCI,’ said Bill Mitchell, PCI President and Chief Executive Officer. ‘PCI has been on an aggressive growth track in the last year, focused on providing customers with quality resources and packaging solutions.

‘We will now have a combined operating space of approximately 2 million ft2, more than 140 commercial and clinical packaging suites, and operations in both the US and UK with more than 2,000 associates. Combined, we will now package product for 19 of the top 20 global pharmaceutical/biotechnology companies.’

Featured companies

PCI Pharma Services: Your bridge between life-changing therapies and patients.
  • Companies:
  • Frazier Healthcare
See more

You may also like

Packaging

Essential elements of package design and artwork creation for commercial success

Read more
Designing a product’s packaging and artwork is often perceived as a last hurdle … and a relatively minor detail in the complex journey to commercialisation

Trending Articles

  1. Dual-chamber packaging systems as a simplification factor in the supply chain Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
  2. Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways
  3. Syncona launches early-stage drug development company, Slingshot Therapeutics The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around inflammatory disease
  4. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios
  5. AstraZeneca to stop production of Pulmicort pMDI Agreements with SkyePharma expected to be terminated

Relevant companies

See more

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Packaging

Essential elements of package design and artwork creation for commercial success

Designing a product’s packaging and artwork is often perceived as a last hurdle … and a relatively minor detail in the complex journey to commercialisation
Distribution

CDMOs deliver increased performance for pharma clients with agility and innovation

Emma Verkaik, Membership & Marketing Director at the BCMPA — the Association for Contract Manufacturing, Packing, Fulfilment & Logistics — gleans insights from members in the pharma sector regarding emerging trends, growth opportunities and the impact of increasing digitalisation, sustainability issues and ESG on the wider industry
Manufacturing

PCI Pharma Services announces multimillion dollar expansion to UK manufacturing facility

New facilities offer innovative equipment and increased capacity to bring highly potent oncology therapies to market
Finance

Humanigen and PCI partner to prepare for commercialisation in the UK

Finance

PCI announces clinical centre of excellence in Boston

The 50,000 sqft centre is currently under construction with an expected completion of Summer 2022
Manufacturing

Biologics and specialty medicines: planning your packaging from clinic to launch (part I)

The pharmaceutical landscape continues to evolve with an ever-increasing focus on specialty medicines. As a result, supply chains are becoming more elaborate, driven by factors such as cold and ultra-cold chain requirements, the growing complexity of delivery systems and the ever more stringent regulatory requirements associated with the packaging of such products
Finance

Thomas H. Lee Partners and Frazier Healthcare Partners acquire Adare

The transaction includes specialty CDMO business, including pharmaceutical technology and microbiome businesses
Subscribe now